Accessibility Menu
 
Alcidion Group logo

Alcidion Group

(ASX) ALC

Current Price$0.10
Market Cap$130.27M
Since IPO (2015)+52%
5 Year-67%
1 Year+20%
1 Month-7%

Alcidion Group Financials at a Glance

Market Cap

$130.27M

Revenue (TTM)

$84.25M

Net Income (TTM)

$1.10M

EPS (TTM)

$0.00

P/E Ratio

33.45

Dividend

$0.00

Beta (Volatility)

0.12 (Low)

Price

$0.10

Volume

1,297,801

Open

$0.10

Previous Close

$0.10

Daily Range

$0.10 - $0.10

52-Week Range

$0.06 - $0.14

ALC News

No articles available.

ALC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alcidion Group

Industry

Health Care Technology

Employees

136

CEO

Kate Quirke

Headquarters

South Yarra, VIC 3141, AU

ALC Financials

Key Financial Metrics (TTM)

Gross Margin

53%

Operating Margin

17%

Net Income Margin

8%

Return on Equity

4%

Return on Capital

9%

Return on Assets

3%

Earnings Yield

2.99%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$130.27M

Shares Outstanding

1.34B

Volume

1.30M

Short Interest

0.00%

Avg. Volume

3.05M

Financials (TTM)

Gross Profit

$35.99M

Operating Income

$7.81M

EBITDA

$1.94M

Operating Cash Flow

$5.76M

Capital Expenditure

$125.00K

Free Cash Flow

$5.64M

Cash & ST Invst.

$17.70M

Total Debt

$1.41M

Alcidion Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$25.47M

+33.6%

Gross Profit

$5.11M

+537.5%

Gross Margin

20.06%

N/A

Market Cap

$130.27M

N/A

Market Cap/Employee

$898.39K

N/A

Employees

145

N/A

Net Income

$1.33M

+130.7%

EBITDA

$4.57M

+257.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$12.88M

+120.6%

Accounts Receivable

$12.42M

+46.8%

Inventory

$0.00

N/A

Long Term Debt

$636.00K

-52.2%

Short Term Debt

$680.00K

-54.3%

Return on Assets

3.28%

N/A

Return on Invested Capital

8.87%

N/A

Free Cash Flow

$2.60M

+77.4%

Operating Cash Flow

$2.56M

+77.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RCE.AXRecce Pharmaceuticals Ltd
$0.45-3.26%
VLS.AXVita Life Sciences Limited
$2.52+1.41%
ACW.AXActinogen Medical Limited
$0.03+3.03%
ONE.AXOneview Healthcare PLC
$0.18+5.71%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.62-0.11%
APLSApellis Pharmaceuticals
$40.26+1.36%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$81.00-0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.22+0.10%

Questions About ALC

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.